Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Status:
Completed
Trial end date:
2010-04-26
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving sulindac together with tamoxifen works in
treating patients with desmoid tumor. Sulindac may stop the growth of cancer cells by
blocking the enzymes necessary for cancer cell growth. Hormone therapy using tamoxifen may
fight cancer by blocking the use of estrogen. Combining sulindac with tamoxifen may kill more
cancer cells.